Wisconsin Senate Bill SB692

Wisconsin 2025-2026 Regular Session

• Introduced: 12/2/25
• Refer: 12/2/25
• Report Pass: 2/3/26
• Engrossed: 2/11/26
• Refer: 2/13/26
• Enrolled: 2/26/26
• Chaptered: 3/13/26
• Passed: 3/13/26

Caption

Listing of carfentanil under the Uniform Controlled Substances Act and providing a penalty.

Impact

The bill establishes criminal penalties for manufacturing, distributing, or delivering carfentanil, with the severity of the felony charge depending on the amount involved. Violating the law could result in a Class E felony for amounts of 10 grams or less, a Class D felony for amounts exceeding 10 grams but not more than 50 grams, and a Class C felony for amounts over 50 grams. This change is expected to enhance law enforcement's ability to combat the proliferation of carfentanil and its analogs, thereby aiming to reduce incidents of drug overdose deaths linked to these substances.

Summary

Senate Bill 692 aims to revise the classification of carfentanil under the Uniform Controlled Substances Act from a synthetic opiate listed under Schedule II to a fentanyl analog listed under Schedule I. This reclassification reflects the growing concerns regarding the dangers associated with carfentanil, particularly its potency and potential for abuse. By categorizing it as a Schedule I substance, SB692 imposes stricter penalties for offenses related to carfentanil, aligning state law with the increasing recognition of its risks.

Contention

While the bill is framed as a necessary step to address public health concerns, it may face opposition from advocates who argue that harsher penalties do not effectively solve drug addiction issues. Critics may contend that higher penalties can disproportionately impact marginalized communities and have limited success in deterring drug offenses. The ongoing debate underscores the complexity of drug policy, where the balance between public safety and humane treatment of addiction remains contentious.